Thema small and medium-sized enterprises

A pioneer of IMMUCOTHEL has passed

A pioneer of IMMUCOTHEL has passed

The urologist Karl-Friedrich Klippel was intensely focused on bladder cancer. He has now died at the age of 76. biosyn Arzneimittel GmbH will always hold his name in honorable remembrance. At our biotechnology corporation, the former president of the German non-profit Society of Biological Cancer Defense (Gesellschaft für Biologische Krebsabwehr e.V.) was a major force driving the development of and providing scientific support for IMMUCOTHEL, our drug for the management of superficial carcinoma of the urinary bladder, also referred to as non-muscle-invasive bladder cancer (NMIBC).

Read more...

After celebrating the 20th anniversary of World Cancer Day biosyn reinforces its commitment to cancer research and awareness

After celebrating the 20th anniversary of World Cancer Day biosyn reinforces its commitment to cancer research and awareness

The theme of World Cancer Day is “I am and I will” to let individuals and companies show how they are committed to act in preventing cancer. In 2020, biosyn joined the organizers in the initiative led by the Union for International Cancer Control (UICC) in speaking out and standing up for a cancer-free world and shared its own stories like those by its production manager Dr. Büchler and its favorite sea snail.

Read more...